Skip to main content
. 2020 Jan 21;10:810. doi: 10.1038/s41598-020-57800-6

Figure 4.

Figure 4

Successful pilot screening of active compounds affecting SE in the automated and miniaturized system. Four compounds belonging to the HDACi family (Oxamflatin, Scriptaid, SAHA and TSA) were tested in 24-well plates at three different concentrations (0.1, 1 and 10 µM), as potential active compounds affecting C. arabica embryo differentiation. Cell clusters were exposed for 24 h to treatment before washing. (a) Embryo regeneration was scored after 9 weeks. The “CTRL” group was untreated (control). Bars show the mean of triplicate samples (n = 18 wells/HDACi/concentration/replicate) and error bars represent the SD. Differences between treated clusters and the control were analysed with a one-way ANOVA test (***P < 0.001). (b) Picture showing the increased embryo yield in the wells treated with 1 µM TSA (bottom) vs control wells (top). (c) The total area occupied by cell clusters was monitored during the embryo regeneration period. Plotted values are the mean of triplicate samples (n = 18 wells/treatment/replicate) and error bars represent the SD. Differences between clusters treated with 1 µM TSA and the control were analysed with a t-test (***P < 0.001). Cell cluster growth followed an exponential trendline (R² = 0.93) up to the sixth week. (d–f) Pictures of an emerged globular-shaped, heart-shaped and torpedo-shaped embryo after 6, 7 and 8 weeks under embryo regeneration conditions, respectively.